rare disease

March 4, 2016March 16, 2016

IPF Patient Survey Reveals Fear, Worry Most Commonly Experienced Emotions When Diagnosed

An international online survey with more than 500 participants suffering from idiopathic pulmonary fibrosis (IPF) provided a picture into the real-life emotions of these patients. The survey was conducted by Germany-based Boehringer Ingelheim ... Read more

December 8, 2015December 8, 2015

New Approach in Pulmonary Alveolar Microlithiasis Treatment Holds Promise

COPD, News

Scientists from University of Cincinnati have identified specific biomarkers and a potential therapy to treat pulmonary alveolar microlithiasis (PAM). Their research, entitled “Modeling pulmonary alveolar microlithiasis by epithelial deletion of the ... Read more

February 16, 2015November 5, 2015

SteadyMed Preps for IPO to Fund PAH Drug Delivery Commercialization

News, Pulmonary Hypertension

SteadyMed Therapeutics, an Israeli based specialty pharmaceutical company that focuses on the development of drug product candidates to treat rare and chronic diseases with unmet parenteral (not delivered via the ... Read more